Breaking Finance News

UniStrip Fights Against LifeScan’s Antitrust Violations

UniStrip Technologies sues LifeScan, a Johnson & Johnson (NYSE: JNJ) company over a violation of the Sherman and Clayton Acts.

UniStrip alleges that LifeScan instituted anti-competitive campaigns such as withholding rebates, cooperative marketing funds and other incentives from wholesalers and retailers offering UniStrip’s flagship product, UniStrip1.

The diabetes test strips produced by UniStrip, cleared by the FDA, are a low cost, highly accurate alternative to LifeScan’s UltraBlue test strip.  UniStrip sells a strip compatible with LifeScan meters for about ten percent of LifeScan’s wholesale price of $60 for 50 strips.

President and CEO of UniStrip, Richard Admani, said, “LifeScan’s product is a flagrant violation of the antitrust laws.  Unfortunately, filing the lawsuit is the only way to stop LifeScan’s exclusionary behavior. Many people with diabetes need a low cost alternative for test strips.  We want to be able to distribute our product without LifeScan threatening or choking off retailers who want to sell our product.”

Disclosure: The author holds no positions in the mentioned securities.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.